[6-K] NatWest Group plc Current Report (Foreign Issuer)

Rhea-AI Filing Summary

NatWest Group plc reports that certain persons discharging managerial responsibility acquired ordinary shares through reinvestment of the ordinary dividend on 12 September 2025. The acquisitions were by the Chairman, several Independent non-executive directors and the Senior Independent Director at a purchase price of £5.2956 per share. The company notes the nominal share value is £1.076923076923077. Transactions occurred on the London Stock Exchange (XLON). Legal Entity Identifier: 2138005O9XJIJN4JPN90. Contact details and signature by Mark Stevens are provided.

Positive

• Board alignment: Multiple directors reinvested their dividends, indicating continued alignment with shareholder returns under the company's shareholding policy.
• Regulatory compliance: The filing clearly discloses PDMR transactions, trading venue (XLON) and the LEI (2138005O9XJIJN4JPN90), meeting Market Abuse Regulation requirements.

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Multiple board members reinvested dividends, indicating alignment with shareholder returns but representing routine disclosure.

The filing documents routine dividend reinvestment by the Chairman and several independent non-executive directors plus the senior independent director at £5.2956 per share on 12 September 2025. From a governance perspective, director participation in dividend reinvestment policies typically signals alignment with shareholder interests and adherence to stated shareholding policies. The disclosure fulfills Market Abuse Regulation obligations by reporting PDMR transactions and identifies the trading venue and LEI, which supports transparency. This event appears procedural and does not itself alter capital structure or signal a material change to operations or financial condition.

Securities Analyst

TL;DR: Transaction is a non-market-moving, compliant PDMR disclosure tied to dividend reinvestment at £5.2956 per share.

The report shows ordinary shares were acquired via dividend reinvestment rather than open-market purchases, so there is no change in outstanding share count or cash flows for the company. The specified price per share provides a reference point for the dividend reinvestment valuation on 12 September 2025. Trading occurred on XLON and the LEI is provided for verification. For investors, this is a transparency disclosure rather than a signal of strategic change or capital raise.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

September, 2025

Commission File Number 001-10306

NatWest Group plc

250 Bishopsgate,

London, EC2M 4AA

United Kingdom

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

The following information was issued as Company announcements in London, England and is furnished pursuant to General Instruction B to the General Instructions to Form 6-K:

16 September 2025

NatWest Group plc

INITIAL NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY (PDMRs) IN ACCORDANCE WITH ARTICLE 19 OF THE MARKET ABUSE REGULATION

NatWest Group plc (the Company) announces that the PDMRs set out below acquired ordinary shares of £1.0769* each in the Company (Shares) (ISIN: GB00BM8PJY71) on 12 September 2025. The Shares were acquired through the reinvestment of the ordinary dividend paid by the Company on 12 September on Shares which the PDMRs had originally acquired in accordance with the Company's Chairman and Non-executive Directors shareholding policy:

Name of PDMR	Position of PDMR	No. of Shares purchased	Purchase price
Rick Haythornthwaite	Chairman	264	£5.2956
Roisin Donnelly	Independent non-executive director	180	£5.2956
Patrick Flynn	Independent non-executive director	169	£5.2956
Geeta Gopalan	Independent non-executive director	48	£5.2956
Yasmin Jetha	Independent non-executive director	158	£5.2956
Stuart Lewis	Independent non-executive director	170	£5.2956
Gillian Whitehead	Independent non-executive director	20	£5.2956
Lena Wilson	Senior Independent Director	149	£5.2956

* Note: the nominal value of ordinary shares without rounding is £1.076923076923077 per share

The transactions took place on the London Stock Exchange (XLON).

Legal Entity Identifier: 2138005O9XJIJN4JPN90

For further information contact:

NatWest Group Investor Relations

Claire Kane

Director of Investor Relations

+44 20 7672 1758

NatWest Group Media Relations 

+44(0)131 523 4205

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

			NatWest Group plc (Registrant)
Date:	16 September 2025			By:	/s/ Mark Stevens
				Name:	Mark Stevens
				Title:	Assistant Secretary

FAQ

What did NatWest Group (RBSPF) disclose in this 6-K?

The company disclosed that the Chairman, several independent non-executive directors and the Senior Independent Director acquired ordinary shares via dividend reinvestment on 12 September 2025 at £5.2956 per share.

Were these purchases made on an exchange and which one?

Yes, the transactions took place on the London Stock Exchange (XLON).

What is the nominal value per NatWest ordinary share stated in the filing?

The nominal value without rounding is £1.076923076923077 per ordinary share.

Does this filing indicate a change in NatWest's capital structure?

No. The filing reports dividend reinvestment by directors and does not state any issuance of new shares or changes to the company's capital structure.

Where can investors obtain further information?

Contact details are provided: NatWest Group Investor Relations, Claire Kane, Director of Investor Relations, +44 20 7672 1758; Media Relations +44(0)131 523 4205.